Results 51 to 60 of about 20,061 (223)
Interventions for hirsutism (excluding laser and photoepilation therapy alone) [PDF]
BACKGROUND Hirsutism occurs in 5% to 10% of women of reproductive age when there is excessive terminal hair growth in androgen-sensitive areas (male pattern). It is a distressing disorder with a major impact on quality of life.
Fedorowicz, Z. +13 more
core +2 more sources
Abstract Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%–13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition as a lifelong endocrine ...
Maria Forslund +5 more
wiley +1 more source
Long‐Term Care of OLP Patients: A Retrospective Study From a Single Hospital Outpatient Clinic
ABSTRACT Background Oral lichen planus (OLP) is a chronic immune‐mediated disorder with malignant potential. However, its real‐world clinical course remains incompletely characterized. This study aimed to describe the natural clinical–histopathological trajectory of OLP in a single tertiary centre and to identify factors associated with dysplasia and ...
F. Scilla +8 more
wiley +1 more source
Background: Hirsutism is a condition characterized by growth of excessive male-pattern (i.e., face, chest, abdomen, lower back, upper arms, and thighs) hair in women.
Asri Asri, Zainal Abidin
doaj +1 more source
Leaf Structure and Hormonal Balance Modulate Host‐Specificity and Pathogenicity of Botrytis cinerea
ABSTRACT Botrytis cinerea, a highly successful necrotrophic fungal plant pathogen, demonstrates a remarkably broad host range, yet the precise factors governing its host specificity and its ability to coexist non‐pathogenically with plants remain unclear. This study systematically assessed host preference in a series of B. cinerea agricultural isolates,
Gautam Anand +12 more
wiley +1 more source
Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks
Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan +4 more
wiley +1 more source
Hirsutism and Depression in Polycystic Ovarian Syndrome
Objective: To determine the frequency of hirsutism and depression in female patients with Polycystic Ovarian Disease and to investigate the association between depression and hirsutism in such patients. Study Design: Cross-sectional study. Place and
Naveed Shehzad Ahmad +5 more
doaj +1 more source
Idiopathic hirsutism – medical and psychological aspects
Introduction. Hirsutism is a condition which results in excess of male pattern hair growth - the androgen dependent hair in females. Excessive hair growth usually starts around puberty.
Grażyna Jarząbek-Bielecka +2 more
doaj +1 more source
ABSTRACT U2 small nuclear RNA auxiliary factor 2 (U2AF2) is an essential pre‐mRNA splicing factor involved in the early stages of pre‐mRNA splicing. To date, multiple individuals have been reported with predominantly heterozygous missense variants presenting intellectual disability, speech and motor delays, seizures, hypotonia, and thin or hypoplastic ...
Amanda Toledo +3 more
wiley +1 more source
ABSTRACT RU 58841 is a nonsteroidal antiandrogen, developed for the treatment of androgen‐dependent conditions. This study aimed to characterize the human metabolism of RU 58841 for the first time and to assess its systemic exposure following topical administration.
Aylin Okutan +4 more
wiley +1 more source

